VisioBrand - Official Site

GST cut leaves some retailers scrambling

GST cut leaves some retailers scrambling: Consumers should check their sales receipts closely for at least another week to make sure they're not paying too much GST on purchases. more »

Lee Valley targets Canada Post in lawsuit over shipping charges: Courier shipping charges levied by Canada Post are at the centre of a class action suit that, if successful, could see at least 57,000 commercial customers refunded overpayments. more »
Wal-Mart's round-the-clock strategy bad for workers: CAW: Retail giant Wal-Mart's decision to expand into round-the-clock shopping does not bode well for workers and their families, a labour leader says. more »
Tot Tower toys recalled for choking hazard: Health Canada issued an advisory Friday warning consumers that Tot Tower blocks are being recalled because young children may choke on plastic laminate peeled from the toys. more »
Maker of tainted dog food agrees to $3.1 million US settlement: A company whose contaminated pet food killed dozens of dogs across the United States will pay $3.1 million US in a settlement with pet owners, an attorney said Friday. more »
Intel quits One Laptop Per Child program: Intel said Thursday it has abandoned the One Laptop Per Child program, dealing a blow to the project seeking to bring low-cost laptops to children in developing countries. more »
Health Canada joins exploding battery investigation: Health Canada has joined the office of the P.E.I. fire marshal in investigating a report of an exploding household battery. more »
Oil prices bump up cost of manufactured goods: StatsCan: Rising petroleum prices nudged up the cost of manufactured products and raw materials in November, Statistics Canada reported. more »
Florida cold snap didn't harm orange crops, say growers: A blast of unusually cold weather doesn't appear to have damaged Florida's multibillion-dollar citrus crop, an industry spokesperson said Thursday. more »
Drug makers spend more on marketing than research: study: U.S. drug companies spend almost twice as much on marketing and promoting medications than on research and development, a new Canadian study says. more »